bioshares report october 2007, page-16

Vyking,

I think you might be on the mark re: a capital raising in 2008, but they sort of have a question mark on it, but are using figures of needing I think 26 million but having 23 million in cash, if the market opens up for Thoratec in the US as expected and they are saying the Ventrassist is superior product to the Heartmate 11, looks like these two companies maybe in the running for market share.

Nova Star had a theory that a US company may make a takeover of Ventrassist, before too long and I tend to agree, if it looks like Ventrassist are going to grab the bigger share from Thoratec, and they need more money to expand, then I think it is a real possiblity, with Ventrassist being a 3rd generation and superior device to Thoratec (when FDA approved) and if Tets Technology is added, it will be miles in front of Thoratec in terms of technology, it may not get to another Capital raising, may get taken over.

Just my thoughts here.................this theory of mine could be the reason, VCR are keeping quite about the Tets Technology..............from Thoratec, until they get there foot in the US door.

Cheers dma